Quick Takeaways
- Ravi Yang Sarin filed SCHEDULE 13D/A for The Oncology Institute, Inc. Common Stock, par value $0.0001 per share (TOI).
- Disclosed ownership: 4.7%.
- Date of event: 26 Mar 2025.
Ravi Yang Sarin - 26 Mar 2025 SCHEDULE 13D/A Report for The Oncology Institute, Inc. Common Stock, par value $0.0001 per share (TOI)
- Filing Manager
- Ravi Yang Sarin
- Reporting Manager
- Ravi Sarin
- Symbol
- TOI
- Shares outstanding
- 87,441,936 shares
- Disclosed Ownership
- 4,109,771 shares
- Ownership
- 4.7%
- Form type
- SCHEDULE 13D/A
- Filing time
- 23 Apr 2025, 18:20:56 UTC
- Date of event
- 26 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Ravi Yang Sarin disclosed 4.7% ownership in The Oncology Institute, Inc. Common Stock, par value $0.0001 per share (TOI) on 26 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 23 Apr 2025, 18:20.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Ravi Sarin | 4.7% | 4,109,771 | 0 | 4,109,771 | /s/ Ravi Sarin | Ravi Sarin | 0001555959 |
| OncologyCare Partners, LLC | 4.7% | 4,109,771 | 0 | 4,109,771 | /s/ Ravi Sarin | Ravi Sarin/Managing Member | 0001752450 |